Skip to Main Content

Paper Details

Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.
Mol Oncol
6
2021
Author NameAffiliation
Inge M van OortRadboud University Medical Center, Radboud Institute for Molecular Life Sciences
Niven MehraRadboud University Medical Center
  • 1 - 2

Datasets

Release 1.2